Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Novo Nordisk A/S (NYSE: NVO) formulated a semaglutide treatment specially designed for obesity when they launched Wegovy in June of 2021
Once you have your dose, remove the needle from the vial
[1] [3] Pharmacologically, the medication's approximately five-day half-life provides some flexibility, but any change to your dosing schedule should follow the FDA guidance of maintaining at least 72 hours between doses
Common side effects of Ozempic include: Diarrhea (8% to 30% of people) Nausea (16% to 44%) Vomiting (5% to 36%) Stomach pain (5.7% to 20%) Constipation (3% to 24%) In clinical studies, up to 12% of people stopped taking Ozempic due to stomach-related side effects
US$ 22.16
US$ 24.52
US$ 20.47
US$ 26.03
US$ 20.38
US$ 27.67
